Trials / Active Not Recruiting
Active Not RecruitingNCT07065773
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
An Open Label Study to Investigate the Safety and Tolerability of Trichostatin A in Patients With Mild to Severe Onychomycosis
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, open label study designed to evaluate the safety, tolerability, and efficacy of topically administered VTR-297 solution. The efficacy objectives of the study will be assessed using fungal culture testing, Neutral Red Staining (NRS) microscopy examination, and KOH microscopy examination after 4 weeks of treatment with VTR-297.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trichostatin A | Topical Study Drug |
Timeline
- Start date
- 2025-05-05
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2025-07-15
- Last updated
- 2026-02-04
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07065773. Inclusion in this directory is not an endorsement.